VEGFR2/CD309 anticorps
VEGFR2
Reactivité: Souris
FACS, IP
Hôte: Rat
Monoclonal
Avas12a1
unconjugated
N° du produit ABIN2141992
-
-
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
-
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
-
Reactivité
-
Souris
-
Hôte
-
Rat
-
Clonalité
-
Monoclonal
-
Conjugué
-
Cet anticorp VEGFR2/CD309 est non-conjugé
-
Application
-
Flow Cytometry (FACS), Immunoprecipitation (IP)
-
Purification
-
Purified by affinity chromatography.
-
Clone
-
Avas12a1
-
Isotype
-
IgG2a kappa
-
Top Product
-
Discover our top product VEGFR2 Anticorps primaire
-
-
-
Indications d'application
-
FC: ≤ 1 μg/test
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Concentration
-
Lot specific
-
Buffer
-
In aqueous buffer with 0.09 % sodium azide, may contain carrier prote/stabilizer.
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles
-
Stock
-
4 °C
-
Stockage commentaire
-
Store at 2-8 °C. Do not freeze. Protect from light
-
-
Lanahan, Zhang, Fantin, Zhuang, Rivera-Molina, Speichinger, Prahst, Zhang, Wang, Davis, Toomre, Ruhrberg, Simons: "The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." dans: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
Lanahan, Hermans, Claes, Kerley-Hamilton, Zhuang, Giordano, Carmeliet, Simons: "VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis." dans: Developmental cell, Vol. 18, Issue 5, pp. 713-24, (2010) (PubMed).
-
-
Antigène
-
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
-
Autre désignation
-
Flk1 (VEGFR2 Produits)
-
Synonymes
-
anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl
-
Pathways
-
Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
-